Cardiovascular disease
Cardiovascular disease (CVD) is an umbrella term encompassing a broad spectrum of disorders affecting the heart and blood vessels, including coronary artery disease (CAD), heart failure, stroke, peripheral artery disease, and arrhythmias such as atrial fibrillation/flutter.
Cardiovascular disease (CVD) is an umbrella term encompassing a broad spectrum of disorders affecting the heart and blood vessels, including coronary artery disease (CAD), heart failure, stroke, peripheral artery disease, and arrhythmias such as atrial fibrillation/flutter. As the leading cause of morbidity and mortality worldwide, CVD arises from a complex and multifactorial interplay of genetic predisposition, metabolic dysfunction, chronic inflammation, oxidative stress, and environmental exposures. Pathophysiologically, the disease is driven by endothelial dysfunction, atherosclerotic plaque formation, thrombosis, and mitochondrial impairment, with upstream contributors including dyslipidemia (particularly elevated LDL cholesterol and lipoprotein(a)), insulin resistance, hypertension, and systemic inflammation mediated through pathways such as the Phosphatidylinositol 3-kinase (PI3K)/Protein kinase B (PKB)/mTOR axis, NF-κB signaling, and Wnt/β-catenin signaling. These shared mechanisms mean CVD rarely occurs in isolation—it is deeply interconnected with type 2 diabetes, chronic kidney disease (CKD), metabolic dysfunction-associated steatotic liver disease (MASLD), and obesity, a convergence now formalized under the cardiovascular-Kidney-Metabolic (CKM) syndrome framework.
Beyond classical risk factors, emerging research has identified roles for epigenetic regulation, including blood DNA methylation, gut microbiota composition, mitochondrial biogenesis, and autophagy dysregulation in CVD pathogenesis. The involvement of Sirtuin 1 (SIRT1), PRKAA1, prostaglandin E2, Gasdermin D (GSDMD)-mediated pyroptosis, and proinflammatory cytokines such as IL-17A illustrates the molecular complexity underlying cardiovascular pathology. Gene Editing Technologies including CRISPR-Cas12a, alongside multi-omics approaches integrating genomics, proteomics, and metabolomics, are increasingly being deployed to disentangle this complexity and identify novel therapeutic targets. CVD thus represents one of the most intensively studied domains in modern biomedical science, with translational research spanning from basic molecular biology to population-scale epidemiology.
Where the papers sit
15 papers from the last 6 months study cardiovascular disease directly · updated from PubMed 15 Nov 2026
Study type 2 clinical trials · 8 observational · 3 human data · 2 unclassified
Themes one subject · 1 paradigm shift
Those 15 are all about one subject.
-
Multifactorial Cardiovascular Risk
Risk assessment is moving beyond conventional factors toward integrated metabolic, inflammatory, renal, lipid, environmental, and aging profiles. Recurrent signals include obesity, diabetes, frailty, accelerated aging, mixed-metal exposure, humidity, substance use, and lipoprotein(a)-linked triglycerides. Cohort and registry analyses increasingly pair biomarkers with genetic risk, lifestyle, and clinical-record data to improve prediction of cardiovascular events and mortality. Early prevention is shifting toward practical interventions such as reducing sedentary time, but causal effects and the value of adding each marker remain unresolved.
Cardiovascular risk is not reliably captured by treating complex biological measures as interchangeable aggregates
The frailty-index study in adults with cardiovascular disease assumed that the identity of individual deficits mattered less than their total count, but found that models using the 46 deficits separately outperformed composite frailty indices and that performance varied with item selection 42696642Sep. The lipoprotein(a) study assumed an essentially uniform, low-density-lipoprotein-like particle, but found that native lipoprotein(a) contains an apolipoprotein E-associated triglyceride signature and that its triglyceride species are associated with incident cardiovascular risk 42612337Aug. Together, these findings replace aggregate interchangeability with a component-resolved account in which the specific deficits or molecular species can carry information that the summary measure conceals.
Papers
The 15 papers from the last 6 months that study cardiovascular disease directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Multifactorial Cardiovascular Risk (15)
- Incremental value of renal, metabolic, and inflammatory markers for prevalent self-reported cardiovascular disease across NHANES cycles: A repeated cross-sectional validation study. Medicine · 6 Nov 2026 PMID 42994907
- Association of Mixed Metal Exposures with Cardiovascular Disease: Insights from a Population-Based Study. Cardiovascular toxicology · 3 Oct 2026 PMID 42828596
- Frailty index deficit interchangeability: an empirical test using random survival forests in adults with cardiovascular disease. Age and ageing · 4 Sept 2026 PMID 42696642
- Oxidative balance-related metabolite signature and incident cardiovascular disease and type 2 diabetes within the PREDIMED trial. Metabolism: clinical and experimental · 2 Sept 2026 PMID 42685820
- Feasibility and Preliminary Efficacy of a "Sit Less" Program Leveraging Fitbit Tracking and Tailored Text Messages in Cardiometabolic Disease: Findings From 2 Parallel Randomized Controlled Trials in Coronary Artery Disease and Type 2 Diabetes. JMIR mHealth and uHealth · 25 Aug 2026 PMID 42641078
- Sex differences in trajectories to cardio-renal and mental health outcomes following the onset of type 2 diabetes: An observational cohort study using multi-state analysis in the UK Clinical Practice Research Datalink. PLoS medicine · 25 Aug 2026 PMID 42640878
- Lipoprotein(a) carries triglyceride species associated with incident cardiovascular disease. Atherosclerosis · 18 Aug 2026 PMID 42612337
- Dynamic Co-Evolution of Obesity-Metabolic-Inflammatory for Cardiovascular Disease Risk Stratification in Middle-Aged and Older Adults: A Data-Driven Joint Trajectory Analysis. Clinical cardiology · 29 Jul 2026 PMID 42522468
- Leveraging free-text clinical records for heart disease classification through structured feature mapping. PloS one · 27 Jul 2026 PMID 42507733
- Prevalence of and Risk Factors for Metabolic Syndrome, Vascular Damage, and Accelerated Aging (MetVasA) After Pediatric Hematopoietic Stem Cell Transplantation for Hematological Malignancy: Protocol for a Cross-Sectional Cohort Study. JMIR research protocols · 16 Jun 2026 PMID 42302269
- Elevated Cardiovascular Risk and Mortality in Type 2 Diabetes Mellitus Patients With Cannabis, Opioid, and Cocaine Use Disorders. Diabetes, obesity & metabolism · 15 Jun 2026 PMID 42297744
- Proxied therapeutic inhibition on sclerostin and atrial fibrillation risk. Communications medicine · 30 May 2026 PMID 42218280
- Implications of Lancet framework definition of obesity in relation to cardiovascular diseases. European journal of preventive cardiology · 28 May 2026 PMID 42207987
- Absolute and physiological humidity metrics and cardiovascular disease risk in aging: a nationwide study from China. International journal of biometeorology · 27 May 2026 PMID 42201577
- Associations of accelerated phenotypic aging, genetic risk and lifestyle with incident asthma, subsequent cardiovascular disease and death: A prospective study using multi-state model. Maturitas · 25 May 2026 PMID 42184546
By study type
Clinical trials (2)
- Oxidative balance-related metabolite signature and incident cardiovascular disease and type 2 diabetes within the PREDIMED trial. Metabolism: clinical and experimental · 2 Sept 2026 PMID 42685820
- Feasibility and Preliminary Efficacy of a "Sit Less" Program Leveraging Fitbit Tracking and Tailored Text Messages in Cardiometabolic Disease: Findings From 2 Parallel Randomized Controlled Trials in Coronary Artery Disease and Type 2 Diabetes. JMIR mHealth and uHealth · 25 Aug 2026 PMID 42641078
Observational studies and case reports (8)
- Incremental value of renal, metabolic, and inflammatory markers for prevalent self-reported cardiovascular disease across NHANES cycles: A repeated cross-sectional validation study. Medicine · 6 Nov 2026 PMID 42994907
- Association of Mixed Metal Exposures with Cardiovascular Disease: Insights from a Population-Based Study. Cardiovascular toxicology · 3 Oct 2026 PMID 42828596
- Sex differences in trajectories to cardio-renal and mental health outcomes following the onset of type 2 diabetes: An observational cohort study using multi-state analysis in the UK Clinical Practice Research Datalink. PLoS medicine · 25 Aug 2026 PMID 42640878
- Lipoprotein(a) carries triglyceride species associated with incident cardiovascular disease. Atherosclerosis · 18 Aug 2026 PMID 42612337
- Dynamic Co-Evolution of Obesity-Metabolic-Inflammatory for Cardiovascular Disease Risk Stratification in Middle-Aged and Older Adults: A Data-Driven Joint Trajectory Analysis. Clinical cardiology · 29 Jul 2026 PMID 42522468
- Prevalence of and Risk Factors for Metabolic Syndrome, Vascular Damage, and Accelerated Aging (MetVasA) After Pediatric Hematopoietic Stem Cell Transplantation for Hematological Malignancy: Protocol for a Cross-Sectional Cohort Study. JMIR research protocols · 16 Jun 2026 PMID 42302269
- Absolute and physiological humidity metrics and cardiovascular disease risk in aging: a nationwide study from China. International journal of biometeorology · 27 May 2026 PMID 42201577
- Associations of accelerated phenotypic aging, genetic risk and lifestyle with incident asthma, subsequent cardiovascular disease and death: A prospective study using multi-state model. Maturitas · 25 May 2026 PMID 42184546
Human data, design not indexed (3)
- Frailty index deficit interchangeability: an empirical test using random survival forests in adults with cardiovascular disease. Age and ageing · 4 Sept 2026 PMID 42696642
- Leveraging free-text clinical records for heart disease classification through structured feature mapping. PloS one · 27 Jul 2026 PMID 42507733
- Implications of Lancet framework definition of obesity in relation to cardiovascular diseases. European journal of preventive cardiology · 28 May 2026 PMID 42207987
Unclassified: not yet indexed with MeSH (2)
- Elevated Cardiovascular Risk and Mortality in Type 2 Diabetes Mellitus Patients With Cannabis, Opioid, and Cocaine Use Disorders. Diabetes, obesity & metabolism · 15 Jun 2026 PMID 42297744
- Proxied therapeutic inhibition on sclerostin and atrial fibrillation risk. Communications medicine · 30 May 2026 PMID 42218280
Written from 15 PubMed abstracts, each one listed by PMID above. Published: 2026-06-15. Last written: 2026-09-06 by GPT. Drafted by language models from published abstracts; not medical advice.